A5058042019- Protein Degradation and Inhibitors
- Cardiac Arrest and Resuscitation
- Malaria Research and Control
- Blood groups and transfusion
- Prostate Cancer Diagnosis and Treatment
- COVID-19 Clinical Research Studies
- Heparin-Induced Thrombocytopenia and Thrombosis
- Renal Diseases and Glomerulopathies
- Economic and Financial Impacts of Cancer
- Global Cancer Incidence and Screening
- Multiple Myeloma Research and Treatments
- Complement system in diseases
- Mechanical Circulatory Support Devices
- SARS-CoV-2 and COVID-19 Research
- Cardiac Structural Anomalies and Repair
University Hospitals Birmingham NHS Foundation Trust
2024
Queen Elizabeth Hospital
2024
University Hospitals Bristol NHS Foundation Trust
2021
University Hospitals Bristol and Weston NHS Foundation Trust
2021
Worthing Hospital
2021
University Hospitals Sussex NHS Foundation Trust
2021
Prostate Cancer UK
2019
Acute thrombotic thrombocytopenic purpura (TTP) is a life-threatening emergency and plasma exchange (PEX) the initial treatment shown to reduce acute mortality.To compare current practice in United Kingdom (UK) against standards set out 2012 British Society of Haematology guideline, better understand issues affecting prompt initiation PEX.The trainee research network HaemSTAR conducted retrospective nationwide review adults presenting UK hospitals with first episode TTP.Data on 148 patients...
Background/Aims Left ventricular assist devices are used to improve the quality of life people waiting for heart transplantation. Driveline infections a significant complication these devices, occurring in 30–40% cases, which could lead threatening sepsis. This study aimed review UK driveline dressing protocols and infection rates determine if national standardisation is possible. Methods Six transplant centres were asked share their comparison. National data obtained from NHS Blood...
6022 Background: Racial differences in prostate cancer-specific survival account for 50% of observed disparities cancer between Caucasians and African Americans. These could be due to sociodemographics, disease characteristics, or management. NCI confers a “comprehensive” designation centers, if they demonstrate excellence research patient care. receiving care at NCICCCs possibly contribute disparity survival. Methods: Using data from Los Angeles Cancer Surveillance Program, we examined...
Dedicated nurse specialists could improve patient experience
Myeloma is a rare, life-limiting blood cancer arising from plasma cells. Early diagnosis imperative to improve clinical outcomes for patients, by both improving overall survival and reducing the morbidity associated with myeloma-related end-organ damage. This can be challenging in primary care, as myeloma difficult diagnose. It may present number of non-specific ways that overlap multitude other conditions. Tests indicate are readily available care. article will describe pathology myeloma,...